[go: up one dir, main page]

DE69331845D1 - IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES USING ANTIGENS WITH INFORMATION SEPITOPES - Google Patents

IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES USING ANTIGENS WITH INFORMATION SEPITOPES

Info

Publication number
DE69331845D1
DE69331845D1 DE69331845T DE69331845T DE69331845D1 DE 69331845 D1 DE69331845 D1 DE 69331845D1 DE 69331845 T DE69331845 T DE 69331845T DE 69331845 T DE69331845 T DE 69331845T DE 69331845 D1 DE69331845 D1 DE 69331845D1
Authority
DE
Germany
Prior art keywords
antigens
hcv
sepitopes
immunoassays
information
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69331845T
Other languages
German (de)
Other versions
DE69331845T3 (en
DE69331845T2 (en
Inventor
Y Chien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25429280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69331845(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DE69331845D1 publication Critical patent/DE69331845D1/en
Publication of DE69331845T2 publication Critical patent/DE69331845T2/en
Publication of DE69331845T3 publication Critical patent/DE69331845T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Immunoassay methods utilizing HCV envelope antigens that contain conformational epitopes reactive with antibodies in serum from infected individuals are useful for screening and diagnosis. These antigens detect antibodies that are not detected by denatured HCV envelope antigens. In addition, these HCV envelope antigens comprised of conformational epitopes are more immunologically reactive than a number of other HCV antigens. This is the first evidence that conformational epitopes may be involved in the immunologic response to HCV antigens.
DE69331845T 1992-07-07 1993-07-02 IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES USING ANTIGENES WITH CONFORMATION SAMPLES Expired - Lifetime DE69331845T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91075992A 1992-07-07 1992-07-07
US910759 1992-07-07
PCT/US1993/006309 WO1994001778A1 (en) 1992-07-07 1993-07-02 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes

Publications (3)

Publication Number Publication Date
DE69331845D1 true DE69331845D1 (en) 2002-06-06
DE69331845T2 DE69331845T2 (en) 2002-08-14
DE69331845T3 DE69331845T3 (en) 2006-10-05

Family

ID=25429280

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331845T Expired - Lifetime DE69331845T3 (en) 1992-07-07 1993-07-02 IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES USING ANTIGENES WITH CONFORMATION SAMPLES

Country Status (19)

Country Link
US (1) US20020150883A1 (en)
EP (1) EP0649537B2 (en)
JP (2) JP3490085B2 (en)
AT (1) ATE216779T1 (en)
AU (1) AU685059B2 (en)
CA (1) CA2139645C (en)
CZ (1) CZ291951B6 (en)
DE (1) DE69331845T3 (en)
DK (1) DK0649537T4 (en)
ES (1) ES2171414T5 (en)
FI (1) FI110546B (en)
HU (1) HUT70473A (en)
NO (1) NO321185B1 (en)
PL (1) PL174686B1 (en)
PT (1) PT649537E (en)
RU (1) RU2126158C1 (en)
SK (1) SK284556B6 (en)
UA (1) UA39944C2 (en)
WO (1) WO1994001778A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
ES2174957T5 (en) 1994-07-29 2006-12-16 Innogenetics N.V. PURIFIED PROTEINS OF HEPATITIS C VIRUS WRAPPING FOR DIAGNOSTIC AND THERAPEUTIC USE.
DE4428705A1 (en) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Recombinant antigen from the NS3 region of the hepatitis C virus
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
WO1996041196A1 (en) * 1995-06-07 1996-12-19 Abbott Laboratories Method for detection of antibody to hepatitis c virus second envelope glycoprotein
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
EP1295126B1 (en) * 1999-07-28 2007-01-24 Novartis Vaccines and Diagnostics, Inc. Hepatitis c viral antigen immunoassay detection systems
DK1350105T3 (en) 2000-06-15 2007-11-12 Novartis Vaccines & Diagnostic Immunoassays for Enti-HCV Antibodies
EP1829891B1 (en) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immunoassays for Anti-HCV Antibodies
AR045702A1 (en) 2001-10-03 2005-11-09 Chiron Corp COMPOSITIONS OF ASSISTANTS.
JP4585314B2 (en) 2002-09-09 2010-11-24 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド HCV assay
WO2004071414A2 (en) * 2003-02-05 2004-08-26 Genzyme Corporation Therapeutic anti-hcv (al9) compounds
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
JP4836281B2 (en) * 2004-08-27 2011-12-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド HCV nonstructural protein variants and uses thereof
US8216590B2 (en) 2006-08-25 2012-07-10 Novartis Ag HCV fusion polypeptides
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
FR2984328B1 (en) 2011-12-20 2016-12-30 Bio-Rad Innovations METHOD FOR DETECTING HEPATITIS C VIRUS INFECTION
EP3564384A1 (en) 2013-03-14 2019-11-06 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
EP2970947A4 (en) 2013-03-14 2016-10-12 Abbott Lab Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
US9194873B2 (en) 2013-03-14 2015-11-24 Abbott Laboratories HCV antigen-antibody combination assay and methods and compositions for use therein
US10267803B2 (en) 2015-03-27 2019-04-23 Ortho-Clinical Diagnostics, Inc. HCV NS4A/modified NS3 polypeptides and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
ES2012739T5 (en) 1987-11-18 2001-12-01 Chiron Corp DIAGNOSTICS FOR NANBV.
HU225068B1 (en) 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
DE4040339C2 (en) * 1989-12-18 1999-07-08 Wellcome Found Viral agent
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
PL172133B1 (en) * 1990-04-04 1997-08-29 Chiron Corp A method of creating a combination of hepatitis C (HCV) antigens and a method of detecting anti-hepatitis C (HCV) antibodies EN EN EN EN EN EN
US5443965A (en) * 1990-04-06 1995-08-22 Genelabs Incorporated Hepatitis C virus epitopes
FI913068L (en) * 1990-06-25 1991-12-26 Univ Osaka Res Found NON-A, NON-B HEPATITIS VIRUS PARTICULARS.
KR0181517B1 (en) * 1990-07-09 1999-04-01 나까하라 노부유끼 Non-A Hepatitis-Specific Antigens and Their Uses in the Diagnosis of Hepatitis
CZ289006B6 (en) * 1990-11-08 2001-10-17 Chiron Corporation Hepatitis C virus asialoglycoprotein, pharmaceutical composition in which the asialoglycoprotein is comprised and use thereof
IT1249684B (en) * 1991-07-19 1995-03-09 Sorin Biomedica Spa HEPATITIS VIRUS PROTEIN ENV EPITOPES
US5587285A (en) * 1992-01-31 1996-12-24 University Of Texas System Generation serological assay for monitoring HIV exposure
EP0627000B1 (en) * 1992-01-31 2003-10-29 Abbott Laboratories Mammalian expression systems for hcv proteins

Also Published As

Publication number Publication date
DE69331845T3 (en) 2006-10-05
JP2003329687A (en) 2003-11-19
JP3490085B2 (en) 2004-01-26
PL307178A1 (en) 1995-05-02
CA2139645A1 (en) 1994-01-20
CA2139645C (en) 2003-02-11
SK284556B6 (en) 2005-06-02
EP0649537A1 (en) 1995-04-26
EP0649537B1 (en) 2002-04-24
NO950006L (en) 1995-02-24
CZ291951B6 (en) 2003-06-18
FI950002L (en) 1995-02-27
HU9500008D0 (en) 1995-03-28
US20020150883A1 (en) 2002-10-17
UA39944C2 (en) 2001-07-16
ES2171414T5 (en) 2006-09-01
AU685059B2 (en) 1998-01-15
WO1994001778A1 (en) 1994-01-20
RU94046284A (en) 1997-02-27
HUT70473A (en) 1995-10-30
DK0649537T3 (en) 2002-06-17
NO321185B1 (en) 2006-04-03
JPH07509060A (en) 1995-10-05
AU4662993A (en) 1994-01-31
CZ695A3 (en) 1996-03-13
ES2171414T3 (en) 2002-09-16
SK495A3 (en) 1995-07-11
RU2126158C1 (en) 1999-02-10
NO950006D0 (en) 1995-01-02
EP0649537B2 (en) 2006-02-22
DK0649537T4 (en) 2006-04-10
DE69331845T2 (en) 2002-08-14
FI950002A0 (en) 1995-01-02
ATE216779T1 (en) 2002-05-15
FI110546B (en) 2003-02-14
PL174686B1 (en) 1998-08-31
PT649537E (en) 2002-09-30

Similar Documents

Publication Publication Date Title
DE69331845D1 (en) IMMUNOASSAYS FOR ANTI-HCV ANTIBODIES USING ANTIGENS WITH INFORMATION SEPITOPES
EP0315364A3 (en) Simultaneous immunoassay for the determination of antigens and antibodies
ES2082777T3 (en) A METHOD FOR THE DETECTION OF AN ANTI-BODY AND ANTIGEN IN AN IMMUNO ASSAY.
DE59511054D1 (en) DETERMINATION OF SPECIFIC IMMUNOGLOBULIN USING MULTIPLE ANTIGENS
DK165785A (en) IMMUNOMETRIC PROVISION FOR MULTIPLE PLACES
DE3584035D1 (en) DETECTION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC IGM.
ATE172542T1 (en) ENLARGED WESTERN BLOT FORMAT AND AN IMMUNO TEST METHOD FOR THE DETERMINATION OF VIRAL ANTIBODIES
ATE210680T1 (en) ANTIBODIES TO HYPOPHYSIC ADENYL CYCLASE ACTIVATED PEPTIDE PACAP, HYBRIDOMAS AND DETERMINATION OF PACAP
ATE51709T1 (en) ANTIGENS ASSOCIATED WITH THE EARLY DETECTION OF PREGNANCY IN MAMMALS.
CA2113383A1 (en) Immunometric determination of an antigen or hapten
KR960014336A (en) Monoclonal Antibodies to Human Glycetin, Hybridomas for Producing Such Antibodies, and Methods of Assaying Human Glycetin Using the Antibodies
KR930008155A (en) Monoclonal Antibodies Against Hepatitis Hepatitis Virus (HCV)
ATE119203T1 (en) MONOCLONAL ANTIBODIES OF MOUSE AGAINST THE GP41 PROTEIN OF HUMAN IMMUNE DEFICIENCY SYNDROME VIRUS.
DE3579856D1 (en) IMMUNULOGICAL TEST FOR DETERMINING COMMON, DETERMINING HEPATITIS B ANTIBODIES.
EP0242589A3 (en) Detection of haptens in immunoassay techniques
ATE132267T1 (en) IMMUNE TEST USING ANTIGENS PRODUCED IN HETEROLOGUE ORGANISMS
KR850008620A (en) Methods and reagents for measuring ATL virus antibodies
KR900016464A (en) Monoclonal Antibodies Recognizing the C-terminus of ANP
DE58909219D1 (en) One-step immunoassay for the determination of antigen-specific antibodies of all immunoglobulin classes and a suitable agent.
EP0304329A3 (en) Monoclonal antibodies and hybridomas and sensitized cells for hbs antigen assay
FI904304A0 (en) FOERFARANDE FOER PAOVISANDE AV ANALYTER.
KR850003169A (en) Measurement method and reagent of basic fetal protein
Huebschle et al. ELISA for the detection of Teschen virus antibodies in pig sera.
KR880000794A (en) Reagent Complex for Sandwich Immunoassay
KR880000793A (en) Reagent Complex for Sandwich Immunoassay

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US